4
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001214659-25-014629
Director sold 123,366 shares at an average $2.41 ($296,789)
- Director acquired 100,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
AULT MILTON C III · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-01 | Conversion : show line 1 in the form | +100,000 | $2.32 | $232,000 | 131,626 | I |
| 2025-10-01 | Sale : show line 2 in the form | −36,777 | $2.35 | $86,378 | 94,849 | I |
| 2025-10-02 | Sale : show line 3 in the form | −20,686 | $2.39 | $49,522 | 74,163 | I |
| 2025-10-03 | Sale : show line 4 in the form | −65,903 | $2.44 | $160,889 | 8,260 | I |
| Open-market sales · 123,366 sh · avg $2.41 · $296,789 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-01 | Conversion : show line 5 in the form Series B Convertible Preferred Stock | −232 | $1,000.00 | $232,000 | 607.24 | I |
Loading xslF345X05/marketforms-70943.xml…